Pall Leukocyte Reduction Blood Cardioplegia FilterFeatures and BenefitsThe Pall Leukocyte Reduction Blood Cardioplegia Filter combines leukocyte reduction filtration media with a conventional 40 µm micro-emboli removal screen. The new low volume housing (95 mL) and improved media pleating technique allows easy application in modern blood cardioplegia systems.● Reduces blood cardioplegia of circulating leukocytes, specifically activated neutrophils, which have been implicated as a major cause of myocardial reperfusion injury. (note: the removal efficiency will depend on total volume of blood cardioplegia delivered and the conditions which the blood cardioplegia is administered (i.e. flow, temperature, haemodilution etc).● Incorporates a 40 µm screen capable of retaining gaseous and particulate microemboli.● Designed to handle flow rates up to 350 mL/min, for a 3 litre throughput, over a wide range of cardioplegia administration practices.* For clinical data please see clinical update or contact your Pall representative.